Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial, page-108

I’ve held PAR for years now, having first bought in at 28c, thanks to which my AEP is only 80c, so I’m pretty philosophical about things…(my sympathies though to those many investors who are sitting on some pretty serious losses).
After all this time my reluctant conclusion, supported yet again by the latest big yawn from the sharemarket, is that, while Pentosan will turn out to be a huge boon for arthritis sufferers, and perhaps to humanity more generally, mug shareholders like me are never going to make the motza that I once hoped for, so I’m going to have to be satisfied with warm charitable feelings for having supported all PAR’s priceless research for no personal benefit whatsoever.
GLTAH nevertheless..